{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:39:17Z","timestamp":1790649557491,"version":"4.1.0"},"reference-count":54,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several genetic syndromes have long been associated with a predisposition to the development of leukemia, including bone marrow failure syndromes, Down syndrome, and Li Fraumeni syndrome. Recent work has better defined the leukemia risk and outcomes in these syndromes. Also, in the last several years, a number of other germ line mutations have been discovered to define new leukemia predisposition syndromes, including ANKRD26, GATA2, PAX5, ETV6, and DDX41. In addition, data suggest that a substantial proportion of patients with therapy related leukemias harbor germ line mutations in DNA damage response genes such as BRCA1\/2 and TP53. Recognition of clinical associations, acquisition of a thorough family history, and high index-of-suspicion are critical in the diagnosis of these leukemia predisposition syndromes. Accurate identification of patients with germ line mutations associated with leukemia can have important clinical implications as it relates to management of the leukemia, as well as genetic counseling of family members.<\/jats:p>","DOI":"10.1182\/asheducation-2016.1.302","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T16:05:27Z","timestamp":1480694727000},"page":"302-308","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Germ line mutations associated with leukemias"],"prefix":"10.1182","volume":"2016","author":[{"given":"Christopher C.","family":"Porter","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"26","key":"2019111704045488600_B1","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1182\/blood-2014-12-580001","article-title":"Inherited genetic variation in childhood acute lymphoblastic leukemia","volume":"125","author":"Moriyama","year":"2015","journal-title":"Blood"},{"key":"2019111704045488600_B2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ceb.2015.09.002","article-title":"What is the DNA repair defect underlying Fanconi anemia?","volume":"37","author":"Duxin","year":"2015","journal-title":"Curr Opin Cell Biol"},{"issue":"3-4","key":"2019111704045488600_B3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"issue":"7","key":"2019111704045488600_B4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jmedgenet-2011-100674","article-title":"Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms","volume":"49","author":"Schulz","year":"2012","journal-title":"J Med Genet"},{"issue":"2","key":"2019111704045488600_B5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cncr.29615","article-title":"Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia","volume":"122","author":"Churpek","year":"2016","journal-title":"Cancer"},{"issue":"26","key":"2019111704045488600_B6","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111704045488600_B7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111704045488600_B8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.13096","article-title":"Haematopoietic development and leukaemia in Down syndrome","volume":"167","author":"Roberts","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111704045488600_B9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcl.2014.09.009","article-title":"Down syndrome preleukemia and leukemia","volume":"62","author":"Maloney","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"2019111704045488600_B10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood-2009-07-235291","article-title":"Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children\u2019s Oncology Group","volume":"116","author":"Maloney","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111704045488600_B11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","article-title":"Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group","volume":"115","author":"Hertzberg","year":"2010","journal-title":"Blood"},{"issue":"7494","key":"2019111704045488600_B12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature13115","article-title":"Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia","volume":"508","author":"Li","year":"2014","journal-title":"Nature"},{"issue":"5","key":"2019111704045488600_B13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"2019111704045488600_B14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2141.2010.08314.x","article-title":"Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankf\u00fcrt-M\u00fcnster study group","volume":"151","author":"Harrison","year":"2010","journal-title":"Br J Haematol"},{"issue":"11","key":"2019111704045488600_B15","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","article-title":"RAS diseases in children","volume":"99","author":"Niemeyer","year":"2014","journal-title":"Haematologica"},{"issue":"16","key":"2019111704045488600_B16","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood-2014-03-300319","article-title":"Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia","volume":"124","author":"Chang","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111704045488600_B17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Chang","year":"2013","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111704045488600_B18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2016.14","article-title":"Targeting the PI3K\/Akt pathway in murine MDS\/MPN driven by hyperactive Ras","volume":"30","author":"Akutagawa","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"2019111704045488600_B19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2019111704045488600_B20","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"2019111704045488600_B21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2019111704045488600_B22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood-2014-06-585513","article-title":"Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia","volume":"125","author":"Antony-Debr\u00e9","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111704045488600_B23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5\u2032 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"24","key":"2019111704045488600_B24","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111704045488600_B25","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019111704045488600_B26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"2019111704045488600_B27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"2019111704045488600_B28","doi-asserted-by":"crossref","first-page":"e1005262","DOI":"10.1371\/journal.pgen.1005262","article-title":"Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia","volume":"11","author":"Topka","year":"2015","journal-title":"PLoS Genet"},{"issue":"16","key":"2019111704045488600_B29","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S1470-2045(15)00369-1","article-title":"Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study","volume":"16","author":"Moriyama","year":"2015","journal-title":"Lancet Oncol"},{"key":"2019111704045488600_B30","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1038\/ncomms11478","article-title":"Common genetic variation in ETV6 is associated with colorectal cancer susceptibility","volume":"7","author":"Wang","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"2019111704045488600_B31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2019111704045488600_B32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"issue":"23","key":"2019111704045488600_B33","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","article-title":"Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia","volume":"29","author":"Hof","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111704045488600_B34","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.3324\/haematol.2015.137059","article-title":"Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival","volume":"101","author":"Salmoiraghi","year":"2016","journal-title":"Haematologica"},{"issue":"7","key":"2019111704045488600_B35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2016-03-704973","article-title":"Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia","volume":"128","author":"Irving","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2019111704045488600_B36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"issue":"24","key":"2019111704045488600_B37","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111704045488600_B38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium \u2018care for CMMRD\u2019 (C4CMMRD)","volume":"51","author":"Wimmer","year":"2014","journal-title":"J Med Genet"},{"issue":"3","key":"2019111704045488600_B39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmg.2015.12.014","article-title":"Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome","volume":"59","author":"Ripperger","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"23","key":"2019111704045488600_B40","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111704045488600_B41","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2019111704045488600_B42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/ejh.12450","article-title":"Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis","volume":"94","author":"Li","year":"2015","journal-title":"Eur J Haematol"},{"issue":"10","key":"2019111704045488600_B43","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/leu.2016.124","article-title":"Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia","volume":"30","author":"Cardoso","year":"2016","journal-title":"Leukemia"},{"issue":"8","key":"2019111704045488600_B44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2019111704045488600_B45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111704045488600_B46","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.3324\/haematol.2015.139790","article-title":"Two novel germline DDX41 mutations in a family with inherited myelodysplasia\/acute myeloid leukemia","volume":"101","author":"Li","year":"2016","journal-title":"Haematologica"},{"issue":"10","key":"2019111704045488600_B47","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"2019111704045488600_B48","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/leu.2013.363","article-title":"Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A","volume":"28","author":"Auer","year":"2014","journal-title":"Leukemia"},{"issue":"10","key":"2019111704045488600_B49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3380","article-title":"Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies","volume":"47","author":"Saliba","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"2019111704045488600_B50","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2015-09-668673","article-title":"Germline RBBP6 mutations in familial myeloproliferative neoplasms","volume":"127","author":"Harutyunyan","year":"2016","journal-title":"Blood"},{"issue":"18","key":"2019111704045488600_B51","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood-2014-08-596445","article-title":"Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1","volume":"124","author":"Guo","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111704045488600_B52","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajhg.2012.03.020","article-title":"Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia","volume":"90","author":"Kirwan","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"21","key":"2019111704045488600_B53","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood-2015-11-680199","article-title":"Exome sequencing reveals recurrent germ line variants in patients with familial Waldenstr\u00f6m macroglobulinemia","volume":"127","author":"Roccaro","year":"2016","journal-title":"Blood"},{"issue":"14","key":"2019111704045488600_B54","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood-2013-05-500850","article-title":"Genetic loss of SH2B3 in acute lymphoblastic leukemia","volume":"122","author":"Perez-Garcia","year":"2013","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2016\/1\/302\/1249750\/hem088423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2016\/1\/302\/1249750\/hem088423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T23:47:11Z","timestamp":1718927231000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2016\/1\/302\/20990\/Germ-line-mutations-associated-with-leukemias"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12,2]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2016.1.302","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}